基因酶控制瘤性MYCN蛋白的稳定性
Nailah Smith1, Eduard Reznik1, Brygida Bisikirska2
1Department of Biological Sciences, Columbia University, New York City, New York 10027, United States.
ACS medicinal chemistry letters
|December 20, 2023
概括
天然产品异二和异二通过向CK2和PI3K等关键激酶,间接降解MYCN. 这种方法提供了一种针对神经母细胞细胞中MYCN的新策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- MYCN是神经母细胞瘤 (NBL) 中的一个关键瘤基因,被认为是神经母细胞瘤的关键瘤基因.
- 没有药物可用的无毒药.
- 由于它缺乏正典约束地点.
研究的目的:
- 阐明在MYCN切除中异二和异二的作用机制.
- 为了确定参与维持MYCN稳定性的关键激酶.
- 开发用于MYCN向的新型,具有成本效益的pomiferin类似物.
主要方法:
- 对已识别的激酶进行系统抑制 (CK2,PI3K,CHK1,STK38L,STK38).
- 合成和测试波米费林类似物.
- 对MYCN降解和NBL细胞死亡诱导的评估.
主要成果:
- 确定了一种酶网络 (CK2,PI3K,CHK1,STK38L,STK38),可以保持MYCN的稳定性.
- 这些激酶的抑制导致MYCN降解和NBL细胞死亡.
- 合成的波米费林类似物保留了MYCN消除活性.
结论:
- 在NBL细胞中为MYCN建立了一个新的间接准策略.
- 证明了针对已识别的激酶网络的治疗潜力.
- 波米费林类似物是有希望的,具有成本效益的治疗道.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Microtubule Instability
5.1K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.1K


